This is the eighth indication approved for Xarelto.
Drug is the only respiratory therapy that can be given at home every 8 weeks.
How the first oral GLP-1 oral treatment for type 2 diabetes is unique and how it will be priced compared to other GLP-1 medications.
Targeted therapy gives new hope to patients with an aggressive form of lung cancer.
The new drug is an add-on to levodopa/carbidopa for Parkinson’s patients experiencing “off” episodes.
Blockbuster drug could be key to Humira’s successor.
FDA approved the third oncology drug in the US that targets a key genetic driver of cancer, rather than a specific tumor.
While FDA’s drug approval time is generally improving, the agency needs to speed up generic drug application reviews, according to a new report.
FDA approved yet another indication for pembrolizumab (Keytruda) to treat patients with recurrent, locally advanced or metastatic, squamous cell carcinoma of the esophagus (ESCC).
Drug to treat prostate cancer is expected to produce a major windfall for two pharma makers.